This analysis was designed to evaluate the association between coping strategies and breast cancer survival among Black and White women in a large population-based study. A total of 442 Black and 405 White US women diagnosed with invasive breast cancer during 1985-1986 and actively followed for survival through 1994 were administered a modified Folkman and Lazarus Ways of Coping questionnaire. Coping strategies were characterized via factor analyses of the responses. Hazard ratios associated with coping strategies were estimated using Cox proportional hazards models, with adjustment for age, race, tumor stage, study location, tumor hormone responsiveness, comorbidity, health insurance status, smoking, relative body weight, and alcohol consumption. Emotion-focused coping strategies were significantly associated with survival. Expression of emotion was associated with better survival (hazard ratio = 0.6; 95% confidence interval: 0.4, 0.9). When it was considered jointly with the presence or absence of perceived emotional support, women reporting low levels of both emotional expression and perceived emotional support experienced poorer survival than women reporting high levels of both (hazard ratio = 2.5; 95% confidence interval: 1.7, 3.7). Similar risk relations were evident for Blacks and Whites and for patients with early and late stage disease. These results suggest that the opportunity for emotional expression may help improve survival among patients with invasive breast cancer. Ever since popularization of the notion that women with a "fighting spirit" had better breast cancer survival than women who were compliant (1), there has been a good deal of research interest in the role that different ways of coping with illness may play in breast cancer prognosis. The "fighting spirit," along with denial, were two psychological responses first identified by British researchers from clinical interviews conducted among 69 early stage breast cancer patients who subsequently experienced better 5-year survival than women whose responses were characterized as "stoic acceptance" or "helplessness/hopelessness" (1). Follow-up of these patients 10 and 15 years later found the same survival differences as the earlier study (2, 3). Similar findings were also reported in 1979 from a small study of 35 women with metastatic breast cancer being treated at the Johns Hopkins Hospital (Baltimore, Maryland) which characterized long term survivors as those who had expressed more negative emotions earlier in their treatment (4).
Ever since popularization of the notion that women with a "fighting spirit" had better breast cancer survival than women who were compliant (1) , there has been a good deal of research interest in the role that different ways of coping with illness may play in breast cancer prognosis. The "fighting spirit," along with denial, were two psychological responses first identified by British researchers from clinical interviews conducted among 69 early stage breast cancer patients who subsequently experienced better 5-year survival than women whose responses were characterized as "stoic acceptance" or "helplessness/hopelessness" (1) . Follow-up of these patients 10 and 15 years later found the same survival differences as the earlier study (2, 3) . Similar findings were also reported in 1979 from a small study of 35 women with metastatic breast cancer being treated at the Johns Hopkins Hospital (Baltimore, Maryland) which characterized long term survivors as those who had expressed more negative emotions earlier in their treatment (4) .
Since then, there has been a mix of studies reporting positive (5) and negative (6) (7) (8) (9) (10) (11) associations. The concept of coping and adaptation to specific stressors such as chronic illness has been intensively evaluated in the psychological literature (12) (13) (14) (15) (16) . Most of this research has relied upon small samples of predominately White clinical or community populations. The analysis described here was designed to evaluate the relation between styles of coping and breast cancer survival among Black and White women in a large population-based multicenter study.
MATERIALS AND METHODS

Study population
Subjects were selected from breast cancer patients enrolled in the National Cancer Institute's Black/White Cancer Survival Study, a large population-based study designed to investigate racial differences in cancer survival rates. A detailed description of the study's design has been published previously (17) . The study protocol and consent form were approved by the Committee for the Protection of Human Subjects at California's Office of Statewide Health Planning and Development, as well as by the institutional review boards governing the two southern study centers. A total of 1,222 women diagnosed with primary breast cancer between January 1, 1985, and December 31, 1986 , were included in the study. The patients were identified through the population-based cancer registries of three US metropolitan areas: Atlanta, Georgia; New Orleans, Louisiana; and San Francisco/Oakland, California. From each metropolitan area, 70 percent of all Black patients with newly diagnosed breast cancer were randomly selected for inclusion. These patients were frequency-matched by age group (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) , and 65-79 years) to newly diagnosed White breast cancer patients who resided within the same metropolitan area.
Coping factor development
Styles of coping were assessed through a series of questions designed to be similar to those in the Folkman and Lazarus Ways of Coping questionnaire (13) . Respondents were asked the extent to which (how often) they used 30 different coping strategies during the month after learning of their diagnosis. We performed factor analysis on these responses in order to reduce the coping measures to conceptually meaningful latent factors (representing distinct strategies of coping). Factor analysis is a statistical procedure used to extract a small number of unifying features from a large number of correlated variables. Initially, we carried out the analysis using an oblique rotation, since it was expected that the factors would be highly intercorrelated. We then used orthogonal and varimax rotations to see whether measures with low loadings could achieve a higher and more acceptable loading using alternative rotations. The final model was tested and improved upon via confirmatory factor analysis. Minor modifications were made to the model to improve its fit, which was within an acceptable range. There were no major differences in fit for Black participants versus White participants.
Through this analysis, we identified seven coping factors; they are described in the Appendix table. Four measures (avoiding people, blaming oneself, getting angry at people, and going along with one's fate) did not load well with any of the factors and were subsequently dropped from the analysis. Using the results of the confirmatory factor analysis, we then computed scores for each patient as weighted means of the elements comprising each factor. To represent the degree to which each patient used a given coping factor, we created indicator variables (high, medium, low) based on the factor distribution (terciles) for the Black/White Cancer Survival Study population. We created a "coping repertoire" variable to investigate whether survival differences existed for women who relied heavily on many different coping strategies versus very few. We composed the coping repertoire variable by summing the number of coping factors for which a patient's score exceeded the median of the study population and created a categorical variable to characterize whether a woman relied heavily on few (0-1), some (2-4), or many (5-7) coping factors.
Covariables
Information on covariables was collected from three sources: abstracts of hospital charts supplemented with records from physicians' offices; central pathologic evaluation of breast tumor tissues; and patient interviews. Information on tumor progesterone receptor status, tumor estrogen receptor status, age, and the presence of comorbid conditions at diagnosis was obtained through the medical record abstracts and pathology laboratory results. Progesterone receptor and estrogen receptor status were dichotomized into positive (≥10 fmol/mg) and negative/ borderline (<10 fmol/mg). Tumor stage was recorded according to the tumor-node-metastasis (TNM) system for breast cancer recommended by the American Joint Committee on Cancer (18) . For this analysis, a summary stage variable was created by dichotomizing stage into early (I, IIN 0 ) and late (IINx, III, IV). Comorbidity information was gathered through an intensive review of the hospital records, supplemented with the office records of the attending physicians. For each patient, a measure of comorbidity was calculated by summing the number of major illnesses mentioned in the medical record thought to potentially influence survival or treatment. The process used for gathering and characterizing the comorbidity information is discussed in greater detail elsewhere (17, 19, 20) .
Information on health insurance status, education, family income, emotional support, relative body weight, smoking, and alcohol consumption was obtained from the patient interviews. Level of emotional support was based on a series of questions developed by Seeman and Syme (21) concerning whether or not patients had resources available (e.g., family, friends, others) for discussing illness and other personal problems. The role of treatment in breast cancer survival in this study population is discussed elsewhere (19) . Based on these earlier findings, we did not incorporate treatment information into this analysis because the data were not sufficiently complete (especially for chemotherapy) and the earlier analysis found that after adjustment for tumor stage, treatment did not independently predict breast cancer survival in this study population (19) . While most interviews (60 percent) were conducted within 3 months of diagnosis, we created a variable to represent the time interval from diagnosis to interview. All patients were asked about the coping strategies they had used during the first month after learning of their diagnosis. We used this timesince-diagnosis variable to investigate whether the recall of those strategies differed by the amount of time that had elapsed since diagnosis.
Follow-up data
Follow-up information was obtained from the Surveillance, Epidemiology, and End Results database for San Francisco-Oakland and Atlanta and was obtained under special contract with the National Cancer Institute for New Orleans. Breast cancer deaths were defined as those with International Classification of Diseases, Ninth Revision, code 174 listed as the underlying cause of death. Survival time (in months) was calculated from the date of diagnosis to the date of death or the most recent follow-up. Patients who died of causes other than breast cancer during the follow-up period were counted as having withdrawn from the study at the time of death, and their data were treated as censored in the survival analysis. Because Surveillance, Epidemiology, and End Results data for all three regions were considered complete only through the end of 1994, survival time was truncated at December 31, 1994.
Analysis
Race and stage differences in coping styles were examined using frequency tables and χ 2 tests for independence. The relation between reported coping strategies and the time that had elapsed between diagnosis and interview was explored in several ways. Scatterplots, Spearman rank correlations, and cross-tabulations of categorized data with χ 2 statistics offered no evidence that the distribution of coping factors varied by time from diagnosis to interview. Multivariate Cox regression models were used to investigate the relation between coping strategies and breast cancer survival. Each coping factor was considered separately, and all initial models included adjustment for design variables (age, study location), race, and summary stage. In subsequent models, further adjustments were made for comorbidity, relative body weight, progesterone receptor and estrogen receptor status, time from diagnosis to interview, alcohol consumption, smoking, and type of health insurance. To assess whether risk estimates differed by race (Blacks vs. Whites) or tumor stage (late stage vs. early stage), we stratified the data according to these factors and repeated the regression analyses.
The Cox regression analyses were carried out using the PHREG procedure in SAS (22) . Examination of KaplanMeier survival curves and log-minus-log survival plots indicated no apparent violation of the underlying assumption of proportional hazards upon which the Cox regression model is predicated (23, 24) .
RESULTS
By the end of the follow-up period, there had been 218 deaths due to breast cancer (137 among Blacks and 81 among Whites). The median duration of follow-up for women who had not died of breast cancer was 107 months. Median durations of follow-up did not differ by race.
For the purposes of this analysis, only women for whom completed interview information was available were considered eligible. Of the 1,222 women identified with invasive breast cancer, 1,013 completed the interview, for an overall response rate of 83 percent. Response rates did not differ substantially between Blacks (81.2 percent) and Whites (84.8 percent). Reasons for nonparticipation included physician refusal (2.9 percent); the physician's being ill or deceased or having moved (2.0 percent); patient refusal (7.4 percent); the patient's being ill or deceased or having moved (3.1 percent); and other miscellaneous reasons (1.8 percent). Furthermore, patients were excluded from this analysis if they had in situ cancer (n ϭ 89), unknown vital status at the last follow-up (n ϭ 2), unknown stage at diagnosis (n ϭ 36), or missing data on coping questions (n ϭ 39). Thus, the survival analysis was conducted with a sample of 847 women, 442 (52.2 percent) of whom were Black and 405 (47.8 percent) of whom were White.
The distributions of selected covariates are shown in table 1. With the exception of age (which was a matching variable), Blacks and Whites differed with regard to all characteristics examined. Compared with Whites, Blacks were more likely to have low socioeconomic status indicators, late stage disease, estrogen receptor negative and progesterone receptor negative tumors, comorbidity at diagnosis, and a high body mass index and were more likely to be current smokers. However, Blacks were less likely to drink alcohol.
Racial and stage differences in coping
Blacks appeared to use a substantially different constellation of coping strategies than Whites. As table 2 illustrates, the distributions for all coping factors except avoidance varied significantly by race. Blacks were more likely to rely heavily on suppressing emotions, wishful thinking, and positive reappraisal, while Whites were more apt to use higher levels of expressing emotions, problem-solving, and escapism.
With the exception of avoidance, which was somewhat more common among patients with early stage disease, the distributions of coping factors did not differ significantly by stage (table 2) . Likewise, coping repertoires did not vary by race or by stage of disease (table 3) .
Coping and breast cancer survival
The adjusted hazard ratios for breast cancer mortality associated with each of the coping factors are presented in table 4. After adjustment for age, study location, race, and summary stage of disease, emotion-focused coping strategies were significantly associated with risk of breast cancer mortality. The Pearson correlation coefficient for expression and suppression of emotions was -0.51. Expression of emotion was related to better survival (hazard ratio (HR) ϭ 0.6; 95 percent confidence interval (CI): 0.4, 0.9), and suppression of emotion was associated with worse survival (HR ϭ 1.4; 95 percent CI: 1.1, 1.9). These effects were generally consistent across race and stage of disease. The hazard ratios for all other coping factors did not differ significantly from 1. Further adjustment for comorbidity, relative body weight, progesterone receptor and estrogen receptor status, time from diagnosis to interview, alcohol consumption, smoking, education, income, and type of health insurance did not substantially change these results (data not shown). Education, income, and type of health insurance were all highly correlated with race. In multivariate models that included race, type of health insurance was the only socioeconomic variable that remained statistically significant. The hazard ratio for a medium level of wishful thinking among Whites was significantly less than 1 (HR ϭ 0.5; 95 percent CI: 0.3, 0.9) (table 4). The lack of an effect at high levels of wishful thinking and the lack of consistency among other subgroups suggests that this finding was probably an artifact of chance. Hazard ratios estimating the effect of coping repertoire on breast cancer survival (adjusted for design variables, race, and stage) are presented in table 5. These results suggest that patients who rely on many coping strategies may have a modest survival advantage over women who use very few strategies (HR ϭ 0.7; 95 percent CI: 0.4, 1.0). Stratification of the data suggested that this relation may be limited to Whites (HR ϭ 0.4; 95 percent CI: 0.2, 0.8). Further adjustment of the models for progesterone receptor and estrogen receptor status, relative body weight, type of health insurance, comorbidity, smoking, and alcohol consumption did not change these results.
An earlier analysis of survival carried out in this population (25) found that women who perceived low levels of emotional support had worse 5-year breast cancer survival rates than women with high levels of emotional support (HR ϭ 1.8; 95 percent CI: 1.3, 2.5). Using the most recent follow-up data, we reexamined this relation and confirmed this earlier finding (HR ϭ 1.7; 95 percent CI: 1.3, 2.3). * The coping repertoire variable was created by summing the number of coping factors for which a patient's score exceeded the median of the study population and then categorizing women into groups that used few (≤1 factor above the median), some (2-4 factors above the median), or many (5-7 factors above the median) different coping strategies.
† χ 2 test for independence. Given that the current analysis suggested emotion-focused strategies to be the most important coping-related predictors of survival, we further investigated this relation in the context of emotional support. These results, shown in table 6 and figure 1, suggest that the effects of emotional expression vary according to the level of perceived emotional support. The log-likelihood ratio test for interaction indicated that the interaction between these two variables was statistically significant (χ 2 ϭ 27.0, p < 0.01). Patients who reported low levels of emotional expression in conjunction with low levels of emotional support experienced worse survival than women who reported high levels of both (HR ϭ 2.5; 95 percent CI: 1.7, 3.7). Although similar risk relations were evident among Blacks, Whites, and women with late stage disease, the risk was more pronounced among women with early stage tumors. These patients had a nearly fourfold risk of dying from breast cancer if they reported low levels of both emotional expression and emotional support when compared with patients with early stage tumors who reported high levels of both (HR ϭ 3.9; 95 percent CI: 1.5, 10.0).
Explaining the Black/White difference in breast cancer survival was not the primary focus of this analysis. However, our results suggest that differences in coping strategies used by Black and White women do not contribute much to an explanation of the survival differential. The multivariate analysis conducted without the coping variables produced a hazard ratio for race (i.e., for being Black) of 1.7 (95 percent CI: 1.3, 2.2). When emotional expression was added to the model, the hazard ratio did not change substantially and remained statistically significant (HR ϭ 1.6; 95 percent CI: 1.2, 2.1).
DISCUSSION
This large population-based study offered provocative evidence that the opportunity for emotional expression may have a positive prognostic value for breast cancer patients. Evaluation of these findings in the context of perceived emotional support, which was demonstrated to be positively associated with survival in an earlier report from this study (25) , produced even more striking results. Notably, women in our study who reported low levels of both emotional expression and emotional support experienced 2-4 times greater breast cancer mortality than women reporting high levels of both.
There are a number of difficulties involved in making direct comparisons of our study results with those from the literature on this topic. These include differences in measures of coping or psychological response, the tumor characteristics of the patients studied, the availability of data on important covariables, follow-up periods, outcome measures, and analytic strategies. Most studies have used either clinical interviews (1, 3, 7, 9, 26, 27) or standard psychometric instruments (4-6, 8, 10, 11, 27-35) designed primar- † The coping repertoire variable was created by summing the number of coping factors for which a patient's score exceeded the median of the study population and then categorizing women into groups that used few (≤1 factor above the median), some (2-4 factors above the median), or many (5-7 factors above the median) different coping strategies. (1, 3, 5, 8-11, 26, 28, 30, 31) . Few studies have been able to adjust for other prognostic factors that might influence the course of disease (3, 5, 7, 9, 11, 31, 34, 36, 37) . Some studies have considered survival time (3, 7, 9-11, 34, 37, 38) and others have considered time to recurrence (1-3, 5, 6, 9, 34) . Studies of patients with metastatic disease tend to compare short term survival (less than 1 year) with long term survival (4, 8, 35) . Many of these investigations recruit patients into the study 6 or more months after diagnosis, introducing a built-in survival bias (36) . Many analyses are based on simple comparisons of mean values, correlation coefficients, and other univariate statistical procedures (1, 2, 4-6, 8, 10, 26, 35) . These procedures, unlike Cox proportional hazards modeling, do not allow for adjustment for other important prognostic factors, nor do they take into account censoring of the survival data; hence, they provide a less precise estimate of risk. Review articles on psychological interventions generally agree that the diversity of study designs and the general focus on short term outcomes make it difficult to assess the evidence for such programs' influencing cancer survival (39, 40) . The timing of assessment and outcome measures used may be particularly important features to consider when evaluating the literature on this topic. One study which collected data from repeated measures of coping in breast cancer patients over a 3-year period suggested that there were substantial changes in coping strategies over time, but the authors offered few supporting details (10) . Conflicting but more convincing evidence comes from a study which examined both measures of affective distress and cortisol metabolites in breast cancer patients followed for 10 years and reported stable values for both (26) . A recent 5-year study of 74 breast cancer patients in which coping strategies were reassessed every 3-6 months found that coping strategies varied but that this variability was more strongly related to illness-related events (e.g., hospitalization, rehabilitation, recurrence) than to time since diagnosis (41) . This is an important area of uncertainty that the current analysis could not address. While we saw little evidence of differences in coping strategies based on stage at diagnosis or time from diagnosis to interview, we were unable to assess whether and how patients may have changed their coping strategies during the follow-up period. The results presented in this report are based on the coping strategies used during the month following diagnosis. We do not know, for instance, if those women who experienced a recurrence of their disease changed their coping strategies and how those changes may have affected their survival. This is an important issue worthy of future study.
Cohen and Lazarus (12, 42) have emphasized that coping is a process rather than a trait. As such, it can only be evaluated in the context of a particular situation and in the context of the demands and resources that come with that situation (12) . There is evidence that people are more likely to use emotion-based coping strategies in health contexts (14) . Similarly, coping which may be adaptive to short term outcomes is not necessarily adaptive to long term outcomes. There are a number of studies suggesting that emotionbased coping may be associated with poorer disease adaptation (28, 43) but better long term survival (12). While we were not able to evaluate the former possibility, our results support the latter.
Despite the difficulties in comparing study results on this topic, the literature does offer a number of threads of evidence which are consistent with the importance of emotionbased coping for women with breast cancer. Greer and Morris (27) found that patients diagnosed with breast cancer were more likely to have shown both extreme suppression and extreme expression of emotion during a preoperative interview than patients who were subsequently determined to have benign breast disease. In the Johns Hopkins Hospital study, it was the women whom clinicians identified as poorly adjusted to their illness who experienced longer survival (4) . In an interesting study of psychological correlates of natural killer cell activity, Levy et al. (44) observed that the patients with low levels of natural killer cell activity were "well adjusted" to their illness, while patients with high levels were those who were distressed or "maladjusted." Speigel et al. (38) , in reporting on their work with advanced stage breast cancer patients at Stanford University, reported significant differences in survival in favor of women randomized to an intervention group which emphasized support and expression of feelings. Temoshok et al. (45) reported that suppression of emotional responses is a central characteristic of the stoic, accepting, and compliant "Type C" personality, which is associated with poorer prognosis in their studies of melanoma patients. Together, these studies and ours, like those of the British investigators (1-3), suggest that coping strategies which make for a compliant patient who is well adjusted to her illness may be maladaptive for long term survival.
The current study had some notable strengths that addressed a number of limitations common to many previous investigations on this topic. The study population was large and population-based, and one of the few to include Black patients. Furthermore, extensive data were available on other well recognized prognostic factors for breast cancer. Therefore, we were able to adjust our estimates of coping-related risk for many important covariates that previous studies have not been able to adjust for. Considered in the context of other prognostic features, these data suggest that the combination of strong emotional support and an opportunity to express emotions may have a beneficial effect on survival from breast cancer. Coping factor Weight (factor loading) Element * Four elements (avoiding people, blaming oneself, getting angry at people, and going along with one's fate) did not load well with any of the factors and were subsequently dropped.
† These coping elements loaded high on two factors (relaxing the criteria to permit double-loading improved the fit of the model significantly).
